Key considerations in the pharmacotherapy of tuberculous meningitis-Reference-Cited by-同舟云学术

Key considerations in the pharmacotherapy of tuberculous meningitis

Published:2019-07-15 Issue:15 Volume:20 Page:1791-1795
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Wasserman Sean¹²^ORCID,Davis Angharad¹³⁴,Wilkinson Robert J.¹⁴⁵,Meintjes Graeme¹²

Affiliation:

1. Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

2. Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa

3. Faculty of Life Sciences, University College London, London, UK

4. The Francis Crick Institute, London, UK

5. Department of Medicine, Imperial College London, London, UK

Funder

European and Developing Countries Clinical Trials Partnership

Office of Extramural Research, National Institutes of Health

South African Agency for Science and Technology Advancement

South African Medical Research Council

Wellcome Trust

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1638912

Reference24 articles.

1. Tuberculous meningitis

2. HIV-associated tuberculous meningitis – diagnostic and therapeutic challenges

3. Treatment of Tuberculous Meningitis and Its Complications in Adults

4. Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis

5. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linezolid Population Pharmacokinetic Model in Plasma and Cerebrospinal Fluid Among Patients With Tuberculosis Meningitis;The Journal of Infectious Diseases;2023-09-22

2. Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis;2023-04-07

3. Bacterial meningitis in Africa;Frontiers in Neurology;2023-02-14

4. The rabbit model: Pathological manifestations of tuberculous meningitis;Handbook of Animal Models in Neurological Disorders;2023

5. Management of tuberculous meningitis in children;Paediatrics and International Child Health;2021-11-16